Andere talen Nocturne Acquisition Corporation

Aandelen

MBTC

KYG6580S1140

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 03-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
11,66 ^USD	-0,49%		-.--%	+0,08%

31/03	Cognos Therapeutics Inc. heeft de overname van Nocturne Acquisition Corporation (NasdaqCM:MBTC) van een groep aandeelhouders in een omgekeerde fusietransactie geannuleerd.	CI
07/02	Nocturne Acquisition Corporation kondigt wijzigingen in het management aan	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Nocturne Acquisition Corporation(NasdaqCM:MBTC) dropped from NASDAQ Composite Index	03/04
Cognos Therapeutics Inc. cancelled the acquisition of Nocturne Acquisition Corporation from a group of shareholders in a reverse merger transaction.	31/03
Nocturne Acquisition Corporation Announces Management Changes	07/02
Sector Update: Financial Stocks Ease Late Afternoon	05/02
Sector Update: Financial	05/02
Nocturne Acquisition Shares Jump as Stockholders' Vote on Merger With Cognos Therapeutics Postponed Further	05/02
Nocturne Acquisition Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	22/11
Chardan Engaged to Facilitate Nocturne Acquisition Corporation's Business Combination with Cognos Therapeutics, Inc., Paving the Way for NASDAQ Listing	21-09-23
Nocturne Acquisition Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	21-08-23
Nocturne Acquisition Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-06-23
Nocturne Acquisition Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	26-05-23
Nocturne Acquisition Corporation Auditor Raises 'Going Concern' Doubt	26-05-23
NOCTURNE ACQUISITION CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	02-05-23
NOCTURNE ACQUISITION CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	14-04-23
NOCTURNE ACQUISITION CORP : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	06-04-23
NOCTURNE ACQUISITION CORP : Regulation FD Disclosure (form 8-K)	03-04-23
NOCTURNE ACQUISITION CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	09-01-23
NOCTURNE ACQUISITION CORP : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	04-01-23
Nocturne Acquisition in Deal to Merge With Cognos Therapeutics	03-01-23
Cognos Therapeutics Inc. executed a definitive business combination agreement to acquire Nocturne Acquisition Corporation from Nocturne Sponsor, LLC, Polar Asset Management Partners Inc., Periscope Capital Inc, Sea Otter Advisors LLC and others for approximately $120 million in a reverse merger transaction.	03-01-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Nocturne Acquisition Corporation

Aandelen

MBTC

KYG6580S1140

Andere talen

Filters